HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluating the porcine dermis graft InteXen in three-compartment transvaginal pelvic organ prolapse repair.

AbstractINTRODUCTION AND HYPOTHESIS:
The aim was to assess the efficacy of three-compartment pelvic organ prolapse (POP) vaginal repair using the InteXen biocompatible porcine dermal graft as compared to traditional colporrhaphy with sacrospinous ligament suspension.
METHODS:
Preoperative, operative, postoperative and follow-up data were collected retrospectively. Objective recurrence was defined as POP quantification >or= stage II and subjective recurrence as a symptomatic bulge.
RESULTS:
Each group consisted of 63 patients. Surgery time was longer using InteXen (72 +/- 24.5 vs 55 +/- 23.5 min, p = 0.0002). Length of hospital stay (4.6 +/- 1.6 vs 4.9 +/- 2.1 days, p = 0.34) as well as duration of follow-up (37.1 vs 35.7 months, p = 0.45) were equivalent between the two groups. No case of mesh erosion or infection was noted. The objective (17% vs 8%, p = 0.12) and subjective recurrence rates (13% vs 5%, p = 0.12) between the two groups were not statistically different.
CONCLUSIONS:
InteXen was well tolerated but had similar efficacy to traditional colporrhaphy and sacrospinous ligament suspension.
AuthorsRajeev Ramanah, Julian Mairot, Marie-Caroline Clement, Bernard Parratte, Robert Maillet, Didier Riethmuller
JournalInternational urogynecology journal (Int Urogynecol J) Vol. 21 Issue 9 Pg. 1151-6 (Sep 2010) ISSN: 1433-3023 [Electronic] England
PMID20424823 (Publication Type: Comparative Study, Journal Article)
Topics
  • Bioprosthesis
  • Dermis (transplantation)
  • Female
  • Gynecologic Surgical Procedures (methods)
  • Humans
  • Middle Aged
  • Pelvic Organ Prolapse (surgery)
  • Prosthesis Design
  • Recurrence
  • Treatment Outcome
  • Vagina (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: